Matches in Wikidata for { <http://www.wikidata.org/entity/Q42930387> ?p ?o ?g. }
- Q42930387 description "2011 nî lūn-bûn" @default.
- Q42930387 description "2011年の論文" @default.
- Q42930387 description "2011年論文" @default.
- Q42930387 description "2011年論文" @default.
- Q42930387 description "2011年論文" @default.
- Q42930387 description "2011年論文" @default.
- Q42930387 description "2011年論文" @default.
- Q42930387 description "2011年论文" @default.
- Q42930387 description "2011年论文" @default.
- Q42930387 description "2011年论文" @default.
- Q42930387 description "2011年论文" @default.
- Q42930387 description "2011年论文" @default.
- Q42930387 description "2011年论文" @default.
- Q42930387 description "2011년 논문" @default.
- Q42930387 description "article científic" @default.
- Q42930387 description "article scientific" @default.
- Q42930387 description "article scientifique" @default.
- Q42930387 description "articol științific" @default.
- Q42930387 description "articolo scientifico" @default.
- Q42930387 description "artigo científico" @default.
- Q42930387 description "artigo científico" @default.
- Q42930387 description "artigo científico" @default.
- Q42930387 description "artikel ilmiah" @default.
- Q42930387 description "artikull shkencor" @default.
- Q42930387 description "artikulong pang-agham" @default.
- Q42930387 description "artykuł naukowy" @default.
- Q42930387 description "artículo científico publicado en 2011" @default.
- Q42930387 description "artículu científicu espublizáu en 2011" @default.
- Q42930387 description "bilimsel makale" @default.
- Q42930387 description "bài báo khoa học" @default.
- Q42930387 description "naučni članak" @default.
- Q42930387 description "scienca artikolo" @default.
- Q42930387 description "scientific article published on October 2011" @default.
- Q42930387 description "scientific article published on October 2011" @default.
- Q42930387 description "scientific article published on October 2011" @default.
- Q42930387 description "teaduslik artikkel" @default.
- Q42930387 description "tieteellinen artikkeli" @default.
- Q42930387 description "tudományos cikk" @default.
- Q42930387 description "vedecký článok" @default.
- Q42930387 description "vetenskaplig artikel" @default.
- Q42930387 description "videnskabelig artikel" @default.
- Q42930387 description "vitenskapelig artikkel" @default.
- Q42930387 description "vitskapeleg artikkel" @default.
- Q42930387 description "vědecký článek" @default.
- Q42930387 description "wetenschappelijk artikel" @default.
- Q42930387 description "wissenschaftlicher Artikel" @default.
- Q42930387 description "επιστημονικό άρθρο" @default.
- Q42930387 description "мақолаи илмӣ" @default.
- Q42930387 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q42930387 description "научна статия" @default.
- Q42930387 description "научная статья" @default.
- Q42930387 description "научни чланак" @default.
- Q42930387 description "научни чланак" @default.
- Q42930387 description "מאמר מדעי" @default.
- Q42930387 description "مقالة علمية نشرت في أكتوبر 2011" @default.
- Q42930387 description "অক্টোবর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q42930387 description "บทความทางวิทยาศาสตร์" @default.
- Q42930387 description "სამეცნიერო სტატია" @default.
- Q42930387 name "Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities" @default.
- Q42930387 name "Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities" @default.
- Q42930387 type Item @default.
- Q42930387 label "Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities" @default.
- Q42930387 label "Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities" @default.
- Q42930387 prefLabel "Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities" @default.
- Q42930387 prefLabel "Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities" @default.
- Q42930387 P1433 Q42930387-8DB5A3A5-088D-4B69-A65F-805064A81D3F @default.
- Q42930387 P1476 Q42930387-B5BC1A3F-D4E3-4E5C-A213-AD84E9A85999 @default.
- Q42930387 P2093 Q42930387-3FCE7719-766D-4D3D-AA2B-BE4516D0CABB @default.
- Q42930387 P2860 Q42930387-06D3646A-848C-4B87-8C04-D8ECE5ED204C @default.
- Q42930387 P2860 Q42930387-2B8AF410-C138-4484-A2A9-9FD15CD25292 @default.
- Q42930387 P2860 Q42930387-37BD084C-F1D0-4763-AE72-BB23523F1691 @default.
- Q42930387 P2860 Q42930387-418401E1-6AF6-4DA3-8B5C-84419A59483A @default.
- Q42930387 P2860 Q42930387-790E4927-3BC6-4B0C-8539-920B291783C6 @default.
- Q42930387 P2860 Q42930387-792F8B04-76D0-4A00-96B5-6C2CBC326E14 @default.
- Q42930387 P2860 Q42930387-86ECB556-B621-467A-8A9E-73D394249BAC @default.
- Q42930387 P2860 Q42930387-92B56FF7-9D88-48C1-88D5-D01577D86418 @default.
- Q42930387 P2860 Q42930387-9BEB4757-04EA-4921-B808-FB7569F62882 @default.
- Q42930387 P2860 Q42930387-AC49BA24-19C8-4444-A036-13A4A4640BA8 @default.
- Q42930387 P2860 Q42930387-B1D8EA2A-7FE4-4728-B612-7AA3954E1D5F @default.
- Q42930387 P2860 Q42930387-BD40F6F3-39AB-4D15-A91F-1DBB0EBCFC81 @default.
- Q42930387 P2860 Q42930387-BFA84C2E-979E-4868-9F65-E38E43AAB2E7 @default.
- Q42930387 P2860 Q42930387-CF17D41F-2B12-4FEB-A9B3-32A5AA421054 @default.
- Q42930387 P2860 Q42930387-D003E8FE-9DED-436C-8550-51F159C42237 @default.
- Q42930387 P2860 Q42930387-DA6CC917-84CC-4A5E-9192-FE371019AF98 @default.
- Q42930387 P2860 Q42930387-E957BA05-A4ED-49ED-8E68-F1D32ED0439B @default.
- Q42930387 P2860 Q42930387-EE8C9B68-EFDA-4B7A-B136-F569A59163BF @default.
- Q42930387 P2860 Q42930387-F030CE7B-CE84-4A37-9ECE-4B1C3298D8A4 @default.
- Q42930387 P2860 Q42930387-F147AF60-0516-487F-BF84-F8D6DB15CDA1 @default.
- Q42930387 P304 Q42930387-612FC9F7-1517-42CC-B5B9-B2BE69DD6252 @default.
- Q42930387 P31 Q42930387-26F9D841-400E-4061-8E64-064C1AC7DC77 @default.
- Q42930387 P31 Q42930387-342a0553-4f26-4343-8cc8-da30063754d2 @default.
- Q42930387 P356 Q42930387-B30341AA-D5BC-4EEC-8EF7-77E9BFFA7B94 @default.
- Q42930387 P407 Q42930387-5CA2C74F-397A-47DD-8F47-AF07215FECF7 @default.
- Q42930387 P433 Q42930387-4B5F36C3-FF10-42C8-A385-118085F1A9DE @default.
- Q42930387 P478 Q42930387-4B82581D-1E58-4CDA-A7F6-13A0B03A6B70 @default.
- Q42930387 P577 Q42930387-D09070B9-1724-4DCD-9668-0AC9C41EFE73 @default.
- Q42930387 P5875 Q42930387-0DEDFA8D-25D4-4766-A5D1-085EBA0A3492 @default.
- Q42930387 P698 Q42930387-D8DF4255-47BA-4393-A4FD-3A2E1193EAF9 @default.
- Q42930387 P921 Q42930387-27795330-8F1C-45EE-B710-A9263D3D855A @default.
- Q42930387 P932 Q42930387-65A30925-B7F1-4BDA-A2E2-92CD8CC76107 @default.